Hypercholesterolemia and prostate cancer: A hospital-based case-control study

Lindsay Magura, Richelle Blanchard, Brian Hope, James R. Beal, Gary G. Schwartz, Abe E. Sahmoun

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objective: High levels of serum cholesterol have been proposed to increase the risk of prostate cancer but the epidemiologic evidence is limited. Methods: We conducted a hospital-based case-control study in Fargo, ND, USA, to examine the association between hypercholesterolemia and prostate cancer. Cases were men with incident, histologically confirmed prostate cancer. Controls were men without clinical cancer who were seen at the same hospital for an annual physical exam. Demographic and clinical data were abstracted from patients' medical charts. Results: From a patient population aged 50 to 74 years old, we obtained data on 312 White cases and 319 White controls. Hypercholesterolemia was defined as total cholesterol greater than 5.17 (mmol/l). Univariate logistic regression showed a significant association between hypercholesterolemia and prostate cancer (odds ratio (OR) = 1.64, 95% confidence interval (CI): 1.19-2.27). This association changed only slightly after adjustment for age, family history of prostate cancer, body mass index, type 2 diabetes, smoking, and multivitamin use (OR = 1.58, 95% CI: 1.11-2.24). A significant association was found between low HDL and prostate cancer (OR = 1.57, 95% CI: 1.04-2.36). High LDL was associated with a 60% increased risk for prostate cancer (OR = 1.60, 95% CI: 1.09-2.34). Compared to never smokers, current smokers had an 84% increased risk for prostate cancer (OR = 1.84, 95% CI: 1.09-3.13). Conclusion: This study adds to recent evidence that hypercholesterolemia may increase the risk of prostate cancer in white men.

Original languageEnglish (US)
Pages (from-to)1259-1266
Number of pages8
JournalCancer Causes and Control
Volume19
Issue number10
DOIs
StatePublished - Dec 1 2008

Fingerprint

Cancer Care Facilities
Hypercholesterolemia
Case-Control Studies
Prostatic Neoplasms
Odds Ratio
Confidence Intervals
Type 2 Diabetes Mellitus
Body Mass Index
Logistic Models
Smoking
Cholesterol
Demography

Keywords

  • Epidemiology
  • Hypercholesterolemia
  • Lipid profiles
  • Prostate cancer
  • Statins

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hypercholesterolemia and prostate cancer : A hospital-based case-control study. / Magura, Lindsay; Blanchard, Richelle; Hope, Brian; Beal, James R.; Schwartz, Gary G.; Sahmoun, Abe E.

In: Cancer Causes and Control, Vol. 19, No. 10, 01.12.2008, p. 1259-1266.

Research output: Contribution to journalArticle

Magura, Lindsay ; Blanchard, Richelle ; Hope, Brian ; Beal, James R. ; Schwartz, Gary G. ; Sahmoun, Abe E. / Hypercholesterolemia and prostate cancer : A hospital-based case-control study. In: Cancer Causes and Control. 2008 ; Vol. 19, No. 10. pp. 1259-1266.
@article{aa794292ec584f75aca744281e8126ea,
title = "Hypercholesterolemia and prostate cancer: A hospital-based case-control study",
abstract = "Objective: High levels of serum cholesterol have been proposed to increase the risk of prostate cancer but the epidemiologic evidence is limited. Methods: We conducted a hospital-based case-control study in Fargo, ND, USA, to examine the association between hypercholesterolemia and prostate cancer. Cases were men with incident, histologically confirmed prostate cancer. Controls were men without clinical cancer who were seen at the same hospital for an annual physical exam. Demographic and clinical data were abstracted from patients' medical charts. Results: From a patient population aged 50 to 74 years old, we obtained data on 312 White cases and 319 White controls. Hypercholesterolemia was defined as total cholesterol greater than 5.17 (mmol/l). Univariate logistic regression showed a significant association between hypercholesterolemia and prostate cancer (odds ratio (OR) = 1.64, 95{\%} confidence interval (CI): 1.19-2.27). This association changed only slightly after adjustment for age, family history of prostate cancer, body mass index, type 2 diabetes, smoking, and multivitamin use (OR = 1.58, 95{\%} CI: 1.11-2.24). A significant association was found between low HDL and prostate cancer (OR = 1.57, 95{\%} CI: 1.04-2.36). High LDL was associated with a 60{\%} increased risk for prostate cancer (OR = 1.60, 95{\%} CI: 1.09-2.34). Compared to never smokers, current smokers had an 84{\%} increased risk for prostate cancer (OR = 1.84, 95{\%} CI: 1.09-3.13). Conclusion: This study adds to recent evidence that hypercholesterolemia may increase the risk of prostate cancer in white men.",
keywords = "Epidemiology, Hypercholesterolemia, Lipid profiles, Prostate cancer, Statins",
author = "Lindsay Magura and Richelle Blanchard and Brian Hope and Beal, {James R.} and Schwartz, {Gary G.} and Sahmoun, {Abe E.}",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/s10552-008-9197-7",
language = "English (US)",
volume = "19",
pages = "1259--1266",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "10",

}

TY - JOUR

T1 - Hypercholesterolemia and prostate cancer

T2 - A hospital-based case-control study

AU - Magura, Lindsay

AU - Blanchard, Richelle

AU - Hope, Brian

AU - Beal, James R.

AU - Schwartz, Gary G.

AU - Sahmoun, Abe E.

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Objective: High levels of serum cholesterol have been proposed to increase the risk of prostate cancer but the epidemiologic evidence is limited. Methods: We conducted a hospital-based case-control study in Fargo, ND, USA, to examine the association between hypercholesterolemia and prostate cancer. Cases were men with incident, histologically confirmed prostate cancer. Controls were men without clinical cancer who were seen at the same hospital for an annual physical exam. Demographic and clinical data were abstracted from patients' medical charts. Results: From a patient population aged 50 to 74 years old, we obtained data on 312 White cases and 319 White controls. Hypercholesterolemia was defined as total cholesterol greater than 5.17 (mmol/l). Univariate logistic regression showed a significant association between hypercholesterolemia and prostate cancer (odds ratio (OR) = 1.64, 95% confidence interval (CI): 1.19-2.27). This association changed only slightly after adjustment for age, family history of prostate cancer, body mass index, type 2 diabetes, smoking, and multivitamin use (OR = 1.58, 95% CI: 1.11-2.24). A significant association was found between low HDL and prostate cancer (OR = 1.57, 95% CI: 1.04-2.36). High LDL was associated with a 60% increased risk for prostate cancer (OR = 1.60, 95% CI: 1.09-2.34). Compared to never smokers, current smokers had an 84% increased risk for prostate cancer (OR = 1.84, 95% CI: 1.09-3.13). Conclusion: This study adds to recent evidence that hypercholesterolemia may increase the risk of prostate cancer in white men.

AB - Objective: High levels of serum cholesterol have been proposed to increase the risk of prostate cancer but the epidemiologic evidence is limited. Methods: We conducted a hospital-based case-control study in Fargo, ND, USA, to examine the association between hypercholesterolemia and prostate cancer. Cases were men with incident, histologically confirmed prostate cancer. Controls were men without clinical cancer who were seen at the same hospital for an annual physical exam. Demographic and clinical data were abstracted from patients' medical charts. Results: From a patient population aged 50 to 74 years old, we obtained data on 312 White cases and 319 White controls. Hypercholesterolemia was defined as total cholesterol greater than 5.17 (mmol/l). Univariate logistic regression showed a significant association between hypercholesterolemia and prostate cancer (odds ratio (OR) = 1.64, 95% confidence interval (CI): 1.19-2.27). This association changed only slightly after adjustment for age, family history of prostate cancer, body mass index, type 2 diabetes, smoking, and multivitamin use (OR = 1.58, 95% CI: 1.11-2.24). A significant association was found between low HDL and prostate cancer (OR = 1.57, 95% CI: 1.04-2.36). High LDL was associated with a 60% increased risk for prostate cancer (OR = 1.60, 95% CI: 1.09-2.34). Compared to never smokers, current smokers had an 84% increased risk for prostate cancer (OR = 1.84, 95% CI: 1.09-3.13). Conclusion: This study adds to recent evidence that hypercholesterolemia may increase the risk of prostate cancer in white men.

KW - Epidemiology

KW - Hypercholesterolemia

KW - Lipid profiles

KW - Prostate cancer

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=55849083093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55849083093&partnerID=8YFLogxK

U2 - 10.1007/s10552-008-9197-7

DO - 10.1007/s10552-008-9197-7

M3 - Article

C2 - 18704722

AN - SCOPUS:55849083093

VL - 19

SP - 1259

EP - 1266

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 10

ER -